GEMA Stock Overview
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a licensed bank for personal storage of cord blood stem cells and tissue of the umbilical cord in Russia and the CIS countries. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₽672.00 |
| 52 Week High | ₽1,250.00 |
| 52 Week Low | ₽601.00 |
| Beta | 0.41 |
| 11 Month Change | 0% |
| 3 Month Change | -0.22% |
| 1 Year Change | -26.96% |
| 33 Year Change | 4.84% |
| 5 Year Change | n/a |
| Change since IPO | -2.40% |
Recent News & Updates
Shareholder Returns
| GEMA | RU Healthcare | RU Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.4% |
| 1Y | -27.0% | 5.3% | 4.8% |
Return vs Industry: GEMA underperformed the Russian Healthcare industry which returned 3.8% over the past year.
Return vs Market: GEMA exceeded the Russian Market which returned -38.2% over the past year.
Price Volatility
| GEMA volatility | |
|---|---|
| GEMA Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in RU Market | 9.4% |
| 10% least volatile stocks in RU Market | 2.3% |
Stable Share Price: GEMA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GEMA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | n/a | www.gemabank.ru |
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a licensed bank for personal storage of cord blood stem cells and tissue of the umbilical cord in Russia and the CIS countries. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company is a subsidiary of Human Stem Cells Institute PJSC.
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Fundamentals Summary
| GEMA fundamental statistics | |
|---|---|
| Market cap | ₽1.00b |
| Earnings (TTM) | ₽127.10m |
| Revenue (TTM) | ₽261.17m |
7.9x
P/E Ratio3.8x
P/S RatioIs GEMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GEMA income statement (TTM) | |
|---|---|
| Revenue | ₽261.17m |
| Cost of Revenue | ₽37.64m |
| Gross Profit | ₽223.53m |
| Other Expenses | ₽96.43m |
| Earnings | ₽127.10m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 85.13 |
| Gross Margin | 85.59% |
| Net Profit Margin | 48.66% |
| Debt/Equity Ratio | 12.9% |
How did GEMA perform over the long term?
See historical performance and comparison